Yes, Dexedrine is still prescribed in the United States. It remains FDA-approved for treating ADHD in children ages 6 to 17 and narcolepsy in both children and adults. The most recent FDA-approved label was updated in October 2023, and the medication continues to be manufactured and distributed by Amneal Pharmaceuticals. That said, Dexedrine occupies a much smaller slice of the stimulant market than it once did, and many people encounter it only after trying more common options first.
What Dexedrine Actually Is
Dexedrine contains pure dextroamphetamine, one of two mirror-image forms of the amphetamine molecule. It’s considered the more potent of the two forms. Adderall, by comparison, contains a 3:1 mix of dextroamphetamine and levoamphetamine. So Dexedrine delivers a more focused version of the same basic compound, without the secondary form that Adderall includes.
The extended-release version, marketed as Dexedrine Spansule, comes in 5 mg, 10 mg, and 15 mg capsules. It’s classified as a Schedule II controlled substance, the same category as Adderall, Ritalin, and other prescription stimulants. This means refill restrictions apply, and prescriptions typically require direct authorization from a prescriber each time.
How Common It Is Compared to Other Stimulants
Dexedrine is far less commonly prescribed than the stimulants that dominate the market today. In 2023, mixed amphetamine salts (the Adderall family) accounted for roughly 49% of all stimulant prescriptions in the U.S., totaling over 41 million dispensed prescriptions. Methylphenidate products like Ritalin and Concerta made up about 22%, and lisdexamfetamine (Vyvanse) about 19%. Pure dextroamphetamine, including Dexedrine and its generics, falls into the remaining share.
The stimulant landscape also shifted significantly during the Adderall supply shortages of 2022 and 2023. Switching from Vyvanse to mixed amphetamine salts jumped 73% compared to 2021 levels, and switching to methylphenidate products also increased. These shortages reshuffled prescribing patterns across the board, but the general trend is clear: most prescribers reach for Adderall, Vyvanse, or methylphenidate products before Dexedrine.
Why a Doctor Might Still Choose It
Despite being less popular, Dexedrine fills a real clinical niche. Some people respond better to pure dextroamphetamine than to the mixed salts in Adderall. The levoamphetamine component in Adderall can contribute to side effects like jitteriness or increased heart rate in certain individuals. Removing it by switching to Dexedrine sometimes produces a cleaner, smoother effect with fewer peripheral symptoms.
Dexedrine is also one of the few stimulants with a specific FDA indication for narcolepsy, which Vyvanse does not carry. For people with narcolepsy who need an amphetamine-based option, Dexedrine remains a straightforward choice. Its interaction profile is also simpler, with roughly 220 known drug interactions compared to over 400 for Vyvanse.
Cost can play a role too. Because generic dextroamphetamine has been available for decades (the original Dexedrine was approved before 1982), it’s often cheaper than newer branded medications, particularly for patients without insurance or with high copays.
Brand Name vs. Generic Availability
Generic dextroamphetamine sulfate extended-release capsules are FDA-approved and available from multiple manufacturers. The brand-name Dexedrine Spansule capsules can be harder to find at pharmacies, since many stock only the generic version. As of early 2025, neither Dexedrine nor generic dextroamphetamine sulfate appears on the FDA’s drug shortage list, though the broader stimulant supply chain has been under pressure in recent years due to manufacturing quotas and surging demand.
If your pharmacy doesn’t carry the brand name, the generic is pharmaceutically equivalent. You may need to call around or ask your prescriber to specify “generic acceptable” to avoid delays.
How It’s Typically Dosed
For ADHD, the standard starting dose is 5 mg once or twice daily in patients 6 and older, with increases of 5 mg per week until the right balance of symptom control and tolerability is found. Most people stay below 40 mg per day. For narcolepsy, the range is wider, from 5 mg to 60 mg daily depending on the severity of daytime sleepiness. Adolescents 12 and older typically start at 10 mg daily for narcolepsy and increase more quickly.
The extended-release Spansule capsule is designed to last around 12 hours, which for many people covers a full school or work day without needing a second dose. This is comparable in duration to other long-acting stimulants, though individual metabolism varies.
What to Know About Side Effects
Dexedrine carries the same core side effect profile as other amphetamine-based stimulants: decreased appetite, trouble sleeping, dry mouth, elevated heart rate, and increased blood pressure. These are dose-dependent, meaning they tend to get worse at higher doses and improve if the dose is lowered. Weight loss and growth suppression are monitored in children on long-term treatment.
Because it’s pure dextroamphetamine without the levoamphetamine component, some people actually experience fewer peripheral side effects (like muscle tension or a racing heartbeat) compared to Adderall. Others notice no difference. The cardiovascular warnings are the same across all prescription amphetamines: people with structural heart defects, serious heart rhythm problems, or uncontrolled high blood pressure should not take them.
Like all Schedule II stimulants, Dexedrine carries a risk of dependence and misuse. This is a regulatory and medical reality, not unique to this particular drug. The risk is managed through controlled prescribing, regular follow-up visits, and honest conversations with your prescriber about how the medication is working.